Abstract
The aryl hydrocarbon receptor repressor (AhRR) is a member of the aryl hydrocarbon receptor (AhR) signaling cascade, which mediates dioxin toxicity and is involved in regulation of cell growth and differentiation. The AhRR was described as a feedback modulator, which counteracts AhR-dependent gene expression. We investigated the molecular mechanisms of transcriptional regulation of the human AhRR by cloning its regulatory DNA region located in intron I of the AhRR. By means of reporter gene analyses and generation of deletion variants, we identified a functional, 3-methylcholanthrene-sensitive xenobiotic response element (XRE) site. Chromatin immunoprecipitation analyses revealed that the AhRR binds to this XRE, displaying an autoregulatory loop of AhRR expression. In addition we show that an adjacent GC-box is of functional relevance for AhRR transcription, since blocking of this GC-box resulted in a decrease of constitutive and inducible AhRR gene activity. The differences in constitutive AhRR mRNA level observed in HepG2, primary fibroblast, and HeLa cells are directly correlated with CYP1A1 inducibility. We show that the nonresponsiveness of high AhRR-expressing cells toward AhR-agonists is associated with a constitutive binding of the AhRR to XRE sites of CYP1A1. Treatment with the histone deacetylase inhibitor sodium butyrate restored the responsiveness of CYP1A1 in these cell lines, due to the dissociation of AhRR from the XREs. Furthermore, transient AhRR mRNA silencing in untreated HeLa cells was accompanied by an increase of basal CYP1A1 expression, pointing to a constitutive role of the AhRR in regulation of CYP1A1. The functional relevance of the AhRR in high AhRR-expressing primary fibroblasts is discussed.
Footnotes
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.107.016253.
-
ABBREVIATIONS: AhR, aryl hydrocarbon receptor; bHLH, basic helix-loop-helix; PAS, period/aryl hydrocarbon receptor nuclear translocator/single-minded (PER-ARNT-SIM); B(a)P, benzo(a)pyrene; 3-MC, 3-methylcholanthrene; ARNT, aryl hydrocarbon receptor nuclear translocator; XRE, xenobiotic-responsive element; AhRR, aryl hydrocarbon receptor repressor; MitA, mithramycin A; NaB, sodium butyrate; DMSO, dimethyl sulfoxide; MNF, 3′-methoxy-4′-nitroflavone; Sp, specificity protein; PCR, polymerase chain reaction; siRNA, small-interfering RNA; RT, reverse transcription; ChIP, chromatin immunoprecipitation; PBS, phosphate-buffered saline; kb, kilobase(s); bp, base pair(s); HDAC, histone deacetylase; TSA, trichostatin A.
- Received April 12, 2007.
- Accepted September 21, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|